Healthcare Risk Management

Articles

• Bioterrorism Watch: Anthrax aftermath: Adverse drug reactions, vaccine controversy undercut CDC extended treatment offer

  Read more

• Bioterrorism Watch: Side effects undermine anthrax drug adherence

  Read more

• Missed diagnosis leads to $22.5 million IL judgment

  Read more

• Blue Cross goes after doctors’ bad handwriting

  Read more

• Sky high and rising: Limits sought for malpractice in Pennsylvania

  Read more

• Health plan association targets malpractice reform

  Read more

• Leapfrog Group has a new partner on road to safety

  Read more

• Guest Column: It’s a raid! What to do when the feds are at your door

  Read more

• Errors in New England strike two hospitals

  Read more

• Utah hospitals’ Olympic preps can be terror primer

  Read more

• First
• Previous
• 144
• 145
• 146
• 147
• 148
• 149
• 150
• Next
• Last